Search For "epidemiology and microbiology"
Russia develops Delta & Omicron-adapted Sputnik V vaccine
Updated : 3 years, 10 months ago IST
Moscow [Russia], August 23 (ANI): Russia's Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announced the development of the Sputnik V vaccine specifically adapted against Delta and Omicron variants of coronavirus.
Read More
Sputnik V demonstrates strong protection against Omicron variant: Study
Updated : 4 years, 1 month ago IST
Moscow [Russia], May 24 (ANI): Gamaleya National Research Center of Epidemiology and Microbiology on Wednesday said that Sputnik V demonstrated strong protection against Omicron variant of COVID-19.
Read More
Omicron variant could replace Delta strain globally: Head of Russian Gamal
Updated : 4 years, 7 months ago IST
Moscow [Russia], December 13 (ANI/Sputnik): The Omicron strain of the coronavirus could eventually replace the Delta variant, as it is already happening in South Africa, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.
Read More
Omicron-infected patients from S. Africa who arrived in Russia were vaccin
Updated : 4 years, 7 months ago IST
Moscow [Russia], December 11 (ANI/Sputnik): Patients infected with the Omicron variant of COVID-19, who arrived in Russia from South Africa, were earlier vaccinated, their disease is mild, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Micr
Read More
Sputnik V effective against Delta, other variants of coronavirus, says RDI
Updated : 4 years, 12 months ago IST
New Delhi [India], July 12 (ANI): The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) on Monday announced strong results of the study on neutralizing the activity of sera from individuals vacc
Read More
Experts says COVID-19 vaccines effective despite virus mutations
Updated : 5 years ago IST
Moscow [Russia], July 3 (ANI): Coronavirus vaccines remain effective in spite of the virus mutations, said an official of the St. Petersburg Pasteur Institute of Epidemiology and Microbiology on Friday.
Read More
Sputnik V vaccine efficacy confirmed at '91.4 per cent' during Phase 3 tri
Updated : 5 years, 6 months ago IST
Moscow [Russia], December 14 (ANI): The efficacy of the Sputnik V COVID-19 vaccine has been confirmed to be 91.4 per cent, based on data analysis of the final control point of clinical trials, announced the Gamaleya National Center of Epidemiology and Microbiology and the Russian Direct I
Read More
Second batch of Sputnik V coronavirus vaccine for civil circulation being
Updated : 5 years, 10 months ago IST
Moscow [Russia], September 8 (ANI/Sputnik): The second batch of Russia's Sputnik V vaccine against COVID-19 for civil circulation is already being produced by the Gamaleya National Research Institute of Epidemiology and Microbiology, and the Federal Service for Surveillance in Healthcare (Ro
Read More
First batch of Russian COVID-19 Vaccine released into public
Updated : 5 years, 10 months ago IST
Moscow [Russia], September 8 (ANI/Sputnik): The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional del
Read More
Russian COVID-19 Vaccine developers ready to share data with Foreign Colle
Updated : 5 years, 11 months ago IST
Moscow [Russia], July 18 (Sputnik/ ANI): Russia's Gamaleya Institute of Epidemiology and Microbiology has produced a coronavirus vaccine that is patented and more advanced than Western competitors and will be happy to share the technology with foreign colleagues, should they require, the ins
Read More